DOCN rises from Fib level support LONGDOCN ona 120 minute chart has downtrended into the support of a 0.5 Fib retracement from
the rise after the November earnings. and the triple top then trend down from the
last earnings. I believe that is is well situated to rebound toward that triple top again
in the next three weeks until earnings. I realize that based on the inicators a long trade
would be buying weakness but I believe buying at undervalue is a good buy low with
an expectation of 15-18% upside.
Techlong
TQQQ reversal shows early tech market recovery LONGOn the 15 minute chart TQQQ took a dive down through some relative volume voids
shown on the volume profile into a double bottom also showing a transition from
high relative selling volume into some decent buying volume . I can conclude that TQQQ
is in early reversal and will head the other direction through the same volume void which
could allow for a rapid ascent. While I made profit on SQQQ today, for tomorrow I
aspire to make money on TQQQ. I love volatility just as I loved yo-yos as a kid many years
ago. The concept of converting kinetic energy into potential energy has analogies in the
markets - coiling to store momentum and the triggering to unleash it. The chart shows
pertinent levels of the trade plan. As a bottom feeding grinder I am looking for 4% of range for
tomorrow .
UPST mid-term VIEW Pre Earning LONGUPST on the daily chart with 2022-2023 in range shows a downtrend of more than 70% and
now a round bottom reversal. The volume profile shows the high volumes of the high volume
area which is relatively thin and mostly below the current price. That is to say, UPST has a
lot of volume voids to fill on its way back to $162 . The Triple EMA ( 200,100,50) shows
a convergence over a long interval followed by the reversal and now divergence. The
MACD indicator is upgoing as are the trends of the dual RS lines of the RSI indicator. I see
this as a long swing trade or investment while UPST is awaiting earnings next month.
For targets, I plan the red lines generated by the volume profite and so $94 and $161.
UPST is on my current favorite stock list. My current holding includes an option striking $51
for 8/4. I will roll that option over about 8/2 to avoid time decay. Additionally,
I will buy another option striking $75 and expiring on 9/15 costing about $950 at the
market price with the bid/ask spread of about 4%. I expect the combined two call optins
will yield on average 5-7% per trading day and may hold them through the earnings period.
The only downside risk is that an earnings beat is somehow already priced into UPST
and that the momentum will decelerate and fade. Buying the contact cheap and out of
the money seeks to manage that risk.